インディアナ州におけるがん（全種類）の臨床試験
インディアナ州内の拠点で、がん（全種類）に関する31件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト（英語）
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Parkview Research Center /ID# 277651, Fort Wayne
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07155187Daily Hand-Held Vibration Therapy
- Indiana University Health West, Avon
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
- IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
被験者募集中
18歳以上 · 全性別 · 2026/09/30更新 · NCT04207437Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Indiana University, Indianapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Franciscan Health Oncology and Hematology Specialists, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Franciscan St. Francis Health /ID# 279788, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- IN Univ Simon Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796Collection of Tissue Samples for Cancer Research
- Indiana University - Purdue, Indianapolis
被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07169851Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Northwest Cancer Center, Dyer
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Franciscan Health, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05335928Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- IU Health North Hospital, Carmel
- Northwest Cancer Center - Crown Point, Crown Point
- UChicago Medicine Northwest Indiana, Crown Point
- 他13件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Parkview Research Center, Fort Wayne
被験者募集中第3相
18歳以上 · 女性 · 2026/07/28更新 · NCT07022483A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Fort Wayne Medical Oncology And Hematology /ID# 268179, Fort Wayne
- Franciscan St. Francis Health /ID# 280928, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05650632Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT05852717Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
- Indiana University School of Medicine, Indianapolis
被験者募集中健康なボランティア歓迎
18歳〜99歳 · 全性別 · 2026/06/24更新 · NCT05346796Childhood Cancer Survivor Study
- Indiana University/Riley Hospital for Children, Indianapolis
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/06/17更新 · NCT01120353Galleri® in the Medicare Population.
- Community Health Network Anderson, Anderson
- Community Health Network North, Fishers
- Community Health Network East, Indianapolis
- 他3件
被験者募集中健康なボランティア歓迎
50歳以上 · 全性別 · 2026/05/22更新 · NCT05673018A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- GSK Investigational Site, Fort Wayne
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06551142The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
- University Hospital Clinical Research Center, Indianapolis
- Purdue Clinical Research Center, West Lafayette
被験者募集中
45歳〜75歳 · 全性別 · 2026/05/14更新 · NCT07086833TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Goshen Center for Cancer Care, Goshen
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/02/24更新 · NCT06207032Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT02984761GEMINI-NSCLC: NSCLC Biomarker Study
- Community Health Network, Indianapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/05更新 · NCT05236114A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
- IU Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/05/18更新 · NCT05970497Addressing Tetrachloroethylene Exposure in an Impacted Community
- Purdue University, West Lafayette
被験者募集中
18歳〜99歳 · 全性別 · 2025/03/18更新 · NCT05819996A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Community Health Network, Inc., Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/02/13更新 · NCT05669430Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。